Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Supreme Court Of India
2002 Gujarat Riots
Enforcement Directorate (ED)
Maharashtra Government
University Grants Commission
Alt News
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / COVAXIN, Covishield will now be available in hospitals and clinics
India

COVAXIN, Covishield will now be available in hospitals and clinics

COVAXIN, Covishield will now be available in hospitals and clinics
Written by Sagar
Jan 27, 2022, 05:39 pm 3 min read
COVAXIN, Covishield will now be available in hospitals and clinics
The market sale approval has been given under the New Drugs and Clinical Trials Rules, 2019.

The Drugs Controller General of India (DCGI) on Thursday granted approval for regular market sale to India's two most prevalent COVID-19 vaccines—COVAXIN and Covishield. This means people will be able to buy the two shots from hospitals and clinics, though they would not be available at medical stores anytime soon. The nod has been given under the New Drugs and Clinical Trials Rules, 2019.

Context
Why does this story matter?
  • Thursday's approval marks a significant step forward in India's battle against the coronavirus pandemic as it would make vaccine availability wider and cheaper.
  • Under India's COVID-19 vaccination program, over 163 crore vaccine doses have already been administered to the eligible population.
  • The nod comes as India witnesses the third wave of coronavirus infections and is currently reporting around three lakh daily new cases.
Details
Key conditions for market sale approval

The approval from DCGI is only for the adult population. The vaccination data will have to be submitted to the DCGI every six months, after which it will be updated on the Co-WIN platform. Adverse events after inoculation would continue to be monitored. Notably, makers of Covishield and COVAXIN—Serum Institute of India and Bharat Biotech—had submitted data from clinical trials for market approval.

Information
How much will the vaccines cost?

The central government is reportedly planning to cap the prices of COVAXIN and Covishield at Rs. 275 per dose under the market sale approval. The existing prices under emergency use authorization are Rs. 1,200 for COVAXIN and Rs. 780 for the latter.

Developments
Expert panel recommended approval last week

Officials at the Pune-based Serum Institute had given an application to the DCGI, seeking a market sale nod for their vaccine. A similar application had been filed by Bharat Biotech along with the required trial data. After reviewing the applications, a subject expert committee of the Central Drugs Standard Control Organisation (CDSCO) recommended approval for both the shots on January 19, 2022.

Vaccines
Both vaccines got emergency nod a year ago

Both COVAXIN and Covishield were the first vaccines to be granted emergency use authorization in India. The approval came on January 3, 2021. COVAXIN is an inactivated virus-based vaccine, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research. It had been found 77.8% effective in trials. Covishield, on the other hand, is a viral vector vaccine with 63% efficacy.

Vaccination
India's vaccination drive

India has so far administered over 163.84 crore coronavirus vaccine doses. At least 72% of the country's adult population has been fully vaccinated. Further, more than 52% of children aged between 15 and 18 years have been inoculated with the first dose. The government is now mulling opening the vaccination drive for the 12-14 year age group in the next phase.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Sagar
Sagar
Twitter
Sagar covers national news for NewsBytes. He has previously worked as an editorial intern at NDTV. Over the course of his near three-year career, Sagar has gained experience in news writing, copy editing, and video production. He holds a Bachelor's degree in Journalism and Mass Communication from the University of Delhi.
Latest
Drugs Controller General of India
COVID-19
COVAXIN
Covishield
COVID-19 Vaccination
Related
Latest
CEO wears AR-enabled contact lens to begin in-eye testing
CEO wears AR-enabled contact lens to begin in-eye testing Technology
Drunk Japanese man loses entire Amagasaki city's personal data
Drunk Japanese man loses entire Amagasaki city's personal data Lifestyle
5 natural and homemade hair spa treatments
5 natural and homemade hair spa treatments Lifestyle
Kajol, Suriya, among Academy's 2022 member invitees
Kajol, Suriya, among Academy's 2022 member invitees Entertainment
Delhi experiencing unbearable heat; monsoon likely after June 29: IMD
Delhi experiencing unbearable heat; monsoon likely after June 29: IMD Delhi
Drugs Controller General of India
Clinical trials for nasal COVID-19 vaccine complete: Bharat Biotech
Clinical trials for nasal COVID-19 vaccine complete: Bharat Biotech India
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years India
COVAXIN likely to get approval for children above 2yrs: Report
COVAXIN likely to get approval for children above 2yrs: Report India
Biological E's Corbevax vaccine approved for children aged 12-18 years
Biological E's Corbevax vaccine approved for children aged 12-18 years India
New anti-COVID drug may cost up to Rs. 3,000: Report
New anti-COVID drug may cost up to Rs. 3,000: Report India
More News
COVID-19
COVID-19: India logs 14,506 fresh cases, 30 more fatalities
COVID-19: India logs 14,506 fresh cases, 30 more fatalities India
COVID-19: India logs 11,793 new cases, 27 more deaths
COVID-19: India logs 11,793 new cases, 27 more deaths India
COVID-19: India reports 17,073 new cases; 21 more deaths
COVID-19: India reports 17,073 new cases; 21 more deaths India
ENG vs IND: Rohit Sharma tests positive for COVID-19
ENG vs IND: Rohit Sharma tests positive for COVID-19 Sports
5 train travel hacks for a comfortable experience
5 train travel hacks for a comfortable experience Lifestyle
More News
COVAXIN
Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension
Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension India
COVID-19: China fighting worst outbreak, UK sets new high
COVID-19: China fighting worst outbreak, UK sets new high World
COVAXIN supply to be increased as teens get COVID-19 vaccines
COVAXIN supply to be increased as teens get COVID-19 vaccines India
PM Modi's address: COVID-19 vaccination for 15-18-year-olds, booster doses announced
PM Modi's address: COVID-19 vaccination for 15-18-year-olds, booster doses announced India
COVAXIN found 50% effective against COVID-19 in first real-world study
COVAXIN found 50% effective against COVID-19 in first real-world study India
More News
Covishield
SII to launch COVID-19 vaccine for children in 6 months
SII to launch COVID-19 vaccine for children in 6 months India
COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective
COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective Technology
COVID-19: India reports 9K+ infections; 477 more deaths
COVID-19: India reports 9K+ infections; 477 more deaths India
No quarantine for fully vaccinated Indians in UK from Monday
No quarantine for fully vaccinated Indians in UK from Monday India
Date of birth on Co-WIN certificates for passengers traveling abroad
Date of birth on Co-WIN certificates for passengers traveling abroad India
More News
COVID-19 Vaccination
COVID-19 vaccines prevented 42L deaths in India in 2021: Report
COVID-19 vaccines prevented 42L deaths in India in 2021: Report India
COVID-19: India logs 17,336 new cases, highest in 4 months
COVID-19: India logs 17,336 new cases, highest in 4 months India
COVID-19: India logs 13,313 fresh cases, 38 more fatalities
COVID-19: India logs 13,313 fresh cases, 38 more fatalities India
COVID-19: India logs 12,249 fresh cases, 13 more fatalities
COVID-19: India logs 12,249 fresh cases, 13 more fatalities India
COVID-19: India logs 9,923 fresh cases, 17 more fatalities
COVID-19: India logs 9,923 fresh cases, 17 more fatalities India
More News
Related
COVAXIN trial data for children aged 2-18 submitted to DCGI
COVAXIN trial data for children aged 2-18 submitted to DCGI India
Biological E-manufactured J&J's single-dose COVID-19 vaccine in India by October
Biological E-manufactured J&J's single-dose COVID-19 vaccine in India by October India
Expert panel recommends emergency use authorization for Zydus's three-dose vaccine
Expert panel recommends emergency use authorization for Zydus's three-dose vaccine India
India's drug regulator approves study on mixing Covishield, COVAXIN jabs
India's drug regulator approves study on mixing Covishield, COVAXIN jabs India
Next News Article
Next News Article

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022